A detailed history of Intech Investment Management LLC transactions in Nuvalent, Inc. stock. As of the latest transaction made, Intech Investment Management LLC holds 14,969 shares of NUVL stock, worth $1.15 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
14,969
Previous 7,783 92.33%
Holding current value
$1.15 Million
Previous $796,000 47.11%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025

BUY
$77.87 - $104.93 $559,573 - $754,026
7,186 Added 92.33%
14,969 $1.17 Million
Q3 2024

Nov 08, 2024

BUY
$67.44 - $112.17 $524,885 - $873,019
7,783 New
7,783 $796,000

Others Institutions Holding NUVL

About Nuvalent, Inc.


  • Ticker NUVL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,977,800
  • Market Cap $3.31B
  • Description
  • Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...
More about NUVL
Track This Portfolio

Track Intech Investment Management LLC Portfolio

Follow Intech Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intech Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intech Investment Management LLC with notifications on news.